These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31386612)

  • 1. Overview and Future Potential of Fast Dissolving Buccal Films as Drug Delivery System for Vaccines.
    Uddin MN; Allon A; Roni MA; Kouzi S
    J Pharm Pharm Sci; 2019; 22(1):388-406. PubMed ID: 31386612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Formulation Strategy to Deliver Combined DNA and VLP Based HPV Vaccine.
    Uddin MN; Henry B; Carter KD; Roni MA; Kouzi SS
    J Pharm Pharm Sci; 2019; 22(1):536-547. PubMed ID: 31718771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buccal and sublingual vaccine delivery.
    Kraan H; Vrieling H; Czerkinsky C; Jiskoot W; Kersten G; Amorij JP
    J Control Release; 2014 Sep; 190():580-92. PubMed ID: 24911355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines.
    Vajdy M; Srivastava I; Polo J; Donnelly J; O'Hagan D; Singh M
    Immunol Cell Biol; 2004 Dec; 82(6):617-27. PubMed ID: 15550120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Review on Current COVID-19 Vaccines and Evaluation of Particulate Vaccine Delivery Systems.
    Shah SM; Alsaab HO; Rawas-Qalaji MM; Uddin MN
    Vaccines (Basel); 2021 Sep; 9(10):. PubMed ID: 34696194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orally-dissolving film for sublingual and buccal delivery of ropinirole.
    Lai KL; Fang Y; Han H; Li Q; Zhang S; Li HY; Chow SF; Lam TN; Lee WYT
    Colloids Surf B Biointerfaces; 2018 Mar; 163():9-18. PubMed ID: 29268211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface modified nanoparticulate carrier constructs for oral mucosal vaccine delivery.
    Mishra N; Singh D; Sharma S; Baldi A
    Curr Drug Deliv; 2014; 11(6):729-43. PubMed ID: 25007830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-layered nanofibrous mucoadhesive films for buccal and sublingual administration of drug-delivery and vaccination nanoparticles - important step towards effective mucosal vaccines.
    Mašek J; Lubasová D; Lukáč R; Turánek-Knotigová P; Kulich P; Plocková J; Mašková E; Procházka L; Koudelka Š; Sasithorn N; Gombos J; Bartheldyová E; Hubatka F; Raška M; Miller AD; Turánek J
    J Control Release; 2017 Mar; 249():183-195. PubMed ID: 27469472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal and sublingual delivery of inactivated polio vaccine.
    Kraan H; Soema P; Amorij JP; Kersten G
    Vaccine; 2017 May; 35(20):2647-2653. PubMed ID: 28400164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal immunisation: adjuvants and delivery systems.
    Moyle PM; McGeary RP; Blanchfield JT; Toth I
    Curr Drug Deliv; 2004 Oct; 1(4):385-96. PubMed ID: 16305400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New routes of administration: epidermal, transcutaneous mucosal ways of vaccination].
    Denis F; Alain S; Ploy MC
    Med Sci (Paris); 2007 Apr; 23(4):379-85. PubMed ID: 17433227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buccal and Sublingual Vaccines: A Review on Oral Mucosal Immunization and Delivery Systems.
    Trincado V; Gala RP; Morales JO
    Vaccines (Basel); 2021 Oct; 9(10):. PubMed ID: 34696284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid-Based Particles: Versatile Delivery Systems for Mucosal Vaccination against Infection.
    Corthésy B; Bioley G
    Front Immunol; 2018; 9():431. PubMed ID: 29563912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal delivery of vaccine antigens and its advantages in pediatrics.
    De Magistris MT
    Adv Drug Deliv Rev; 2006 Apr; 58(1):52-67. PubMed ID: 16516335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in Nanoparticulate Drug Delivery Approaches for Sublingual and Buccal Administration.
    Hua S
    Front Pharmacol; 2019; 10():1328. PubMed ID: 31827435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced mucosal and systemic immune responses following intravaginal immunization with human papillomavirus 16 L1 virus-like particle vaccine in thermosensitive mucoadhesive delivery systems.
    Park JS; Oh YK; Kang MJ; Kim CK
    J Med Virol; 2003 Aug; 70(4):633-41. PubMed ID: 12794729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery strategies to enhance oral vaccination against enteric infections.
    Davitt CJ; Lavelle EC
    Adv Drug Deliv Rev; 2015 Aug; 91():52-69. PubMed ID: 25817337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biocompatible Mater Constructed Microneedle Arrays as a Novel Vaccine Adjuvant- Delivery System for Cutaneous and Mucosal Vaccination.
    Wang T; Wang N
    Curr Pharm Des; 2015; 21(36):5245-55. PubMed ID: 26412356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights in mucosal vaccine development.
    Pavot V; Rochereau N; Genin C; Verrier B; Paul S
    Vaccine; 2012 Jan; 30(2):142-54. PubMed ID: 22085556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal vaccine delivery: Current state and a pediatric perspective.
    Shakya AK; Chowdhury MYE; Tao W; Gill HS
    J Control Release; 2016 Oct; 240():394-413. PubMed ID: 26860287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.